Nowak M A, McLean A R
Department of Zoology, University of Oxford, U.K.
Proc Biol Sci. 1991 Nov 22;246(1316):141-6. doi: 10.1098/rspb.1991.0136.
Vaccination and post-exposure immunization against the human immunodeficiency viruses (HIV-1 and HIV-2) faces the problem of the extensive genetic and antigenic variability of these viruses. This raises the question of what fraction of all possible antigen strains of the virus must be recognized by the immune response to a vaccine to prevent development of acquired immunodeficiency disease (AIDS). The success of a vaccine can depend on the variability of the target epitopes. The different HIV variants must be suppressed faster than new escape mutants can be produced. In this paper the antigenic variation of HIV during an individual infection is described by a stochastic process. The central assumption is that antigenic drift is important for the virus to survive immunological attack and to establish a persistent infection that leads to the development of AIDS after a long incubation period. The mathematical analysis reveals that the fraction of antigenic variants recognized by the immune response, that is induced by a successful immunogen, must exceed 1-1/R, where R is the diversification rate of the virus population. This means that if each HIV strain can produce, on average, five new escape mutants, then more than 80% of the possible variants must be covered by the immunogen. A generic result of the model is that, no matter how immunogenic a vaccine is, it will fail if it does not enhance immune attack against a sufficiently large fraction of strains. Furthermore, it is shown that the timing of the application of post-exposure immunization is important.
针对人类免疫缺陷病毒(HIV - 1和HIV - 2)的疫苗接种及暴露后免疫面临着这些病毒广泛的基因和抗原变异性问题。这就引出了一个问题:疫苗引发的免疫反应必须识别病毒所有可能抗原菌株中的多大比例,才能预防获得性免疫缺陷疾病(AIDS)的发展。疫苗的成功与否可能取决于靶抗原表位的变异性。必须比新的逃逸突变体产生得更快地抑制不同的HIV变体。本文通过一个随机过程描述了个体感染期间HIV的抗原变异。核心假设是抗原漂移对于病毒在免疫攻击下存活并建立持续感染至关重要,这种持续感染在长时间潜伏期后会导致AIDS的发展。数学分析表明,由成功的免疫原诱导的免疫反应所识别的抗原变体比例必须超过1 - 1/R,其中R是病毒群体的多样化率。这意味着,如果每个HIV毒株平均能产生五个新的逃逸突变体,那么免疫原必须覆盖超过80%的可能变体。该模型的一个普遍结果是,无论疫苗的免疫原性如何,如果它不能增强针对足够大部分毒株的免疫攻击,疫苗都会失败。此外,研究表明暴露后免疫接种的时机很重要。